The day the story broke, Reza’s office door was swarmed by reporters. “Is it true?” they shouted. Reza, ever the charismatic showman, smiled and said, “The science is sound, the data is real, and the future is ours to shape.” Yet behind that confident veneer, a storm was gathering.
More insidious are lawsuits filed by entities linked to the Islamic Republic of Iran against Pahlavi in Western courts. Using shell companies or sympathetic claimants, Iranian interests have attempted to sue Pahlavi for “inciting unrest” or “violating sanctions” by encouraging protests against the regime. In 2022, following the Mahsa Amini protests, Pahlavi openly supported the uprising. Shortly thereafter, a lawsuit was filed in a US federal court by an individual claiming to represent Iranian businesses harmed by his “provocations.” Legal analysts widely viewed this as a Strategic Lawsuit Against Public Participation (SLAPP)—designed not to win but to drain Pahlavi’s resources and silence his activism. Most such suits have been dismissed for lack of personal jurisdiction or sovereign immunity grounds, but they illustrate how autocratic regimes exploit Western legal systems to harass exiled dissidents. reza lawsuit
Let me know if you want to add something. The day the story broke, Reza’s office door
Disclaimer: This narrative is a work of fiction inspired by generic legal themes. Any resemblance to real persons or companies, past or present, is purely coincidental. More insidious are lawsuits filed by entities linked
Following the initial agreement, Borchardt’s representatives reportedly attempted to add an NDA to the settlement, offering additional payment for the plaintiffs' silence. Both plaintiffs declined this offer.
Two weeks later, a was filed in the U.S. District Court for the Northern District of California. The plaintiffs—comprising former Virox investors, a consortium of biotech firms, and a handful of patients who had enrolled in Virox’s experimental vaccine trials—claimed:
